These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 2581332)
1. Effects of prostacyclin and of the stable prostacyclin analogue ZK 36374 on forearm blood flow and blood platelet behaviour in man. Cowley AJ; Heptinstall S; Hampton JR Thromb Haemost; 1985 Feb; 53(1):90-4. PubMed ID: 2581332 [TBL] [Abstract][Full Text] [Related]
2. Correlation between platelet behaviour and cold-induced vasoconstriction in man, and the effects of epoprostenol infusion. Cowley AJ; Stainer K; Cockbill S; Heptinstall S Clin Sci (Lond); 1984 Nov; 67(5):511-4. PubMed ID: 6434223 [TBL] [Abstract][Full Text] [Related]
3. Differential inhibition of the platelet activation sequence: shape change, micro- and macro-aggregation, by a stable prostacyclin analogue (Iloprost). Pedvis LG; Wong T; Frojmovic MM Thromb Haemost; 1988 Apr; 59(2):323-8. PubMed ID: 2455359 [TBL] [Abstract][Full Text] [Related]
4. Control of human and animal platelet aggregation by a new prostacyclin analog. Maderna P; Colli S; Sirtori C; Tremoli E; Paoletti R Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():363-9. PubMed ID: 2408447 [TBL] [Abstract][Full Text] [Related]
5. Blood platelet behaviour in mothers and neonates. Andrews NP; Broughton Pipkin F; Heptinstall S Thromb Haemost; 1985 Jun; 53(3):428-32. PubMed ID: 3931289 [TBL] [Abstract][Full Text] [Related]
6. Influence on platelet activity and red cell fluidity of epoprostenol and two stable prostacyclin analogues in vitro. Maurin N Arzneimittelforschung; 1986 Aug; 36(8):1180-3. PubMed ID: 3096342 [TBL] [Abstract][Full Text] [Related]
7. Comparison of inhibitory actions of prostacyclin and a new prostacyclin analogue on the aggregation of human platelet in whole blood. Saniabadi AR; Belch JJ; Lowe GD; Barbenel JC; Forbes CD Haemostasis; 1987; 17(3):147-53. PubMed ID: 2440771 [TBL] [Abstract][Full Text] [Related]
8. Dissociation of antiplatelet effects from myocardial cytoprotective activity during acute myocardial ischemia in cats by a new carbacyclin derivative (ZK 36 375). Schrör K; Darius H; Ohlendorf R; Matzky R; Klaus W J Cardiovasc Pharmacol; 1982; 4(4):554-61. PubMed ID: 6181328 [TBL] [Abstract][Full Text] [Related]
9. Amelioration of the deleterious effects of platelets activated during cardiopulmonary bypass. Comparison of a thromboxane synthetase inhibitor and a prostacyclin analogue. Huddleston CB; Hammon JW; Wareing TH; Lupinetti FM; Clanton JA; Collins JC; Bender HW J Thorac Cardiovasc Surg; 1985 Feb; 89(2):190-5. PubMed ID: 2578591 [TBL] [Abstract][Full Text] [Related]
10. Antifibrillatory action of the stable orally active prostacyclin analogues iloprost and ZK 96 480 in rats after coronary artery ligation. Müller B; Maass B; Stürzebecher S; Skuballa W Biomed Biochim Acta; 1984; 43(8-9):S175-8. PubMed ID: 6083785 [TBL] [Abstract][Full Text] [Related]
11. The effects of prostacyclin (PGI2) on endotoxin shock and endotoxin-induced platelet aggregation in dogs. Fletcher JR; Ramwell PW Circ Shock; 1980; 7(3):299-308. PubMed ID: 7004660 [TBL] [Abstract][Full Text] [Related]
12. Platelet responses observed during and after infusions of the prostacyclin analog ZK 36 374. Yardumian DA; Mackie IJ; Bull H; Machin SJ Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():359-62. PubMed ID: 2408446 [No Abstract] [Full Text] [Related]
13. Platelet alterations in shear flow: dose response of prostacyclin on human platelets. Hung TC; Butter DB; Graham MF; Lewis JH; Zhao JQ; Haubold AD Trans Am Soc Artif Intern Organs; 1983; 29():436-41. PubMed ID: 6424310 [No Abstract] [Full Text] [Related]
14. Interactions between prostacyclin analogue ZK 36374 and heparin in their effects upon platelet function. Yardumian DA; O'Flynn K; Linch DC; Machin SJ Br J Haematol; 1987 Mar; 65(3):325-30. PubMed ID: 2436647 [TBL] [Abstract][Full Text] [Related]
15. Intrathoracic platelet accumulation in the guinea-pig induced by intravenous administration of arachidonic acid--effect of cyclooxygenase and thromboxane synthetase inhibitors. Barrett PA; Butler KD; Shand RA; Wallis RB Thromb Haemost; 1986 Dec; 56(3):311-7. PubMed ID: 3105107 [TBL] [Abstract][Full Text] [Related]
16. Critical evaluation of the in vivo selectivity between hypotensive and platelet antiaggregating actions of iloprost and prostacyclin in beagle dogs. Hermán F; Hadházy P; Magyar K Arch Int Pharmacodyn Ther; 1989; 300():281-91. PubMed ID: 2482710 [TBL] [Abstract][Full Text] [Related]
17. Platelet impedance aggregation in whole blood and its inhibition by antiplatelet drugs. Mackie IJ; Jones R; Machin SJ J Clin Pathol; 1984 Aug; 37(8):874-8. PubMed ID: 6206096 [TBL] [Abstract][Full Text] [Related]
18. Platelet function studies during and after infusions of ZK 36374, a stable prostacyclin analogue, to healthy volunteers. Yardumian DA; Mackie IJ; Brennan EC; Bull H; Machin SJ Haemostasis; 1986; 16(1):20-6. PubMed ID: 2422095 [TBL] [Abstract][Full Text] [Related]
19. Effect of Iloprost (ZK 36 374), a novel prostacyclin analogue, on ADP-induced platelet aggregation. Wadenvik H; Kutti J Acta Haematol; 1985; 73(4):224-7. PubMed ID: 2414956 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of ZK 36374, a stable prostacyclin analogue, on adhesion of rabbit platelets to damaged aorta and serotonin release by adherent platelets. Menys VC; Davies JA Clin Sci (Lond); 1983 Aug; 65(2):149-53. PubMed ID: 6190604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]